CALGARY, ALBERTA--(Marketwired - Apr 24, 2013) - The Fraser Institute will release a new report measuring the length of time it takes Health Canada to approve patented new medicines for public use, on Thursday, April 25 at 6:30 a.m. (Eastern).
Federal Delays in Approving New Medicines compares the speed of Health Canada to that of the European Medicines Agency and the United States Food and Drug Administration in certifying new prescription drugs as safe and effective from 2007 to 2011.
A news release with additional information will be issued via Marketwire at 6:30 a.m. (Eastern) on Thursday, April 25.
The full report will also be available as a free PDF download at www.fraserinstitute.org.
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of 86 think-tanks. Its mission is to measure, study, and communicate the impact of competitive markets and government intervention on the welfare of individuals. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org.
- Budget, Tax & Economy
- Singapore International News
- Health Canada
- European Medicines Agency